On The Pen With Dave Knapp
Dave Knapp brings you your weekly dose of everything in the news about incretin mimetic, diabetes and obesity therapies, like Zepbound and Mounjaro, Ozempic and Wegovy, and even investigational treatments like CagriSema and Retatrutide!
Fantastic podcast
12/07/2024
Dave is amazing source of information for anyone interested in metabolic health. If you are looking for a podcast where factual information is what it’s all about, this is the podcast for you. Dave takes incredibly complex areas like US and European Union drug regulation, research and development of new drugs and technology, clinical trials, pharmaceutical companies quarterly financial reports and takes all of it and then some and makes it easy to understand for the listener. If he doesn’t know or thinks the listener will benefit, he brings on subject matter experts, like obesity doctors, trade association spokespeople, telehealth provider executives or even current clinical trial participants. I’ve learned so much from Dave and his show. Five stars all the way.
Too political
12/14/2024
Helpful news and informative but becoming more and more political. No thank you.
Kind and informative
12/07/2024
Dave is a great guy and I trust his guests and info. It gave me confidence to start Wegovy
A man of the people!
11/26/2024
Dave is the most thorough and robust news source for all GLP1 Updates! He is very involved and always listening to feedback from his community as well. I always am excited when an update comes out from Dave because I know it’s the latest and first update compared to any news source!
About
Information
- CreatorDave Knapp Man On The Mounjaro, Bleav
- Years Active2024 - 2025
- Episodes80
- RatingClean
- Copyright© 2025 On The Pen With Dave Knapp
- Show Website
You Might Also Like
- MedicineUpdated Weekly
- MedicineUpdated Weekly
- Alternative HealthUpdated Weekly
- MedicineUpdated Weekly
- Health & FitnessUpdated Biweekly
- Alternative HealthUpdated Weekly
- NutritionUpdated Weekly